OrbiMed’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

OrbiMed’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,577,982	Closed	-$8.59M	–	168
2019 Q4	$8.59M	Sell	2,577,982 -2,210,914	-46%	-$7.03M	0.12%	84
2019 Q3	$14.6M	Sell	4,788,896 -406,434	-8%	-$1.14M	0.28%	72
2019 Q2	$12.4M	Hold	5,195,330	–	–	0.19%	86
2019 Q1	$19.5M	Hold	5,195,330	–	–	0.3%	76
2018 Q4	$18.7M	Hold	5,195,330	–	–	0.34%	71
2018 Q3	$29.8M	Buy	5,195,330 +1,155,330	+29%	+$6.61M	0.36%	72
2018 Q2	$20.2M	Buy	4,040,000 +2,940,000	+267%	+$15.1M	0.24%	90
2018 Q1	$5.64M	Buy	+1,100,000	New	+$6.62M	0.07%	117

OrbiMed's FOMX Position: Q1 2020 in Review

OrbiMed sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 2,577,982 shares — an estimated $8.59M sold.

OrbiMed first reported a position in FOMX in Q1 2018 and held it in 8 quarters. The position peaked at $29.8M in Q3 2018. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

OrbiMed reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
OrbiMed sold 2,577,982 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $8.59M.
OrbiMed first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2018 and held it in 8 quarters.
OrbiMed's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $29.8M in Q3 2018.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on OrbiMed's 13F filing for Q1 2020, filed 15 May 2020.